Mihai Suceveanu

Dr. Mihai Suceveanu

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
ASAdela Mihaela Serban
Adela Mihaela Serban
ADAlexandra Dadarlat-Pop
Alexandra Dadarlat-Pop
RTRaluca Tomoaia
Raluca Tomoaia
CTCatalin Trifan
Catalin Trifan
AMAdrian Molnar
Adrian Molnar
MSMihai Suceveanu
Mihai Suceveanu
Cardiac tumors are a very rare but heterogenous group of diseases that may reveal themselves through a variety of nonspecific cardiac symptoms that may pose a challenge to the diagnostic process. Myxofibrosarcoma is a particularly rare type of cardiac tumor that carries a poor prognosis, thus making accurate and timely diagnosis essential. A 61-year-old woman presented with fatigue and shortness of breath during mild exercise, symptoms that have progressively worsened during the previous year. Multimodality imaging consisting of transthoracic and transesophageal echocardiography (TTE and TEE), cardiac magnetic resonance (CMR), cardiac computer tomography (CCT), and fluorodeoxyglucose positron emission computer tomography (18F-FDG PET-CT) was used for the diagnosis and postoperative follow-up of a myxofibrosarcoma.

24 November 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
ASAdela Mihaela Serban
Adela Mihaela Serban
ADAlexandra Dadarlat-Pop
Alexandra Dadarlat-Pop
RTRaluca Tomoaia
Raluca Tomoaia
CHClaudia Hagiu
Claudia Hagiu
DADan Axente
Dan Axente
MSMihai Suceveanu
Mihai Suceveanu
Carcinoid heart disease is a rare presentation of the carcinoid syndrome, which is caused by excessive tumoral hormone production and the abundant release of vasoactive substances with systemic expressions. A 62-year-old woman presented with flushing, diarrhea, weight loss, and right-sided heart failure symptoms. Specific carcinoid heart disease features were identified using transthoracic and transesophageal echocardiography at the tricuspid and pulmonic valves. Biomarkers, 99mTc-Tektrotyd scintigraphy, SPECT-CT, and a biopsy later confirmed the diagnosis, and the patient began treatment for the underlying condition.

23 February 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
ASAdela Mihaela Serban
Adela Mihaela Serban
Alexandru AchimAlexandru Achim
Alexandru Achim
DGDana Elena Gavan
Dana Elena Gavan
RTRaluca Tomoaia
Raluca Tomoaia
AMAdrian Molnar
Adrian Molnar
ADAlexandra Dadarlat-Pop
Alexandra Dadarlat-Pop
Infective endocarditis (IE) is common in patients with corrected congenital heart disease (CHD) with a residual lesion, but is rarely found on surgical patches used to close atrial septal defects (ASDs). This is also reflected in the current guidelines that do not recommend antibiotic therapy for patients with a repaired ASD with no residual shunt six months after closure (percutaneous or surgical). However, the situation could be different in the case of mitral valve endocarditis, which causes leaflet disruption with severe mitral insufficiency and could seed the surgical patch. We present herein a 40-year-old male patient with a past medical history of a complete surgically corrected atrioventricular canal defect performed in childhood who presented with fever, dyspnea and severe abdominal pain. Transthoracic and transesophageal echocardiography (TTE and TEE) revealed vegetation at the level of the mitral valve and the interatrial septum. The CT scan confirmed ASD patch endocarditis and multiple septic emboli, guiding the therapeutic management. An accurate evaluation of cardiac structures should be mandatory when a systemic infection is detected in CHD patients, even if the defects were surgically corrected, because the detection and eradication of such infectious foci as well as a surgical reintervention are particularly difficult to achieve in this subpopulation.